Brawn Biotech
20.00
+0.19(+0.96%)
Market Cap₹5.96 Cr
PE Ratio31.40
IndustryHealthcare
Company Performance:
1D+0.96%
1M-10.55%
6M-9.50%
1Y+17.30%
5Y-12.85%
View Company Insightsright
More news about Brawn Biotech
30Sept 25
Brawn Biotech Shareholders Approve Key Resolutions at 40th AGM
Brawn Biotech Limited held its 40th Annual General Meeting on September 30, 2025, via video conferencing. Shareholders approved several important resolutions including the re-appointment of Mr. Amit Kumar as Manager for a five-year term, adoption of a new Memorandum of Association, approval of financial statements, and re-appointment of Mrs. Brij Bala Gupta as director. All resolutions received overwhelming support with 99.99% votes in favor. The meeting, chaired by Mr. Brij Raj Gupta, lasted from 11:00 AM to 11:13 AM, with e-voting open for an additional 30 minutes.
 no imag found
13Aug 25
Brawn Biotech Reports Turnaround with Rs 23.60 Lacs Profit in Q1
Brawn Biotech Limited, a pharmaceutical company, has reported a significant turnaround in its Q1 financial performance. The company posted a profit of Rs 23.60 lacs, compared to losses in previous quarters. Revenue increased substantially to Rs 579.77 lacs, more than doubling from the previous quarter. The company's Earnings Per Share (EPS) improved to Rs 0.89. The statutory auditor conducted a limited review and found no issues with the financial results.
 no imag found
Brawn Biotech
20.00
+0.19
(+0.96%)
1 Year Returns:+17.30%
Industry Peers
Sun Pharmaceutical
1,694.60
(+0.06%)
Divis Laboratories
5,821.00
(-0.61%)
Torrent Pharmaceuticals
4,011.60
(+0.61%)
Lupin
2,279.90
(+0.24%)
Dr Reddys Laboratories
1,217.80
(+0.04%)
Cipla
1,200.90
(+0.71%)
Zydus Life Science
866.30
(+0.24%)
Mankind Pharma
2,017.70
(+0.96%)
Aurobindo Pharma
1,340.40
(+0.50%)
Alkem Laboratories
5,236.50
(-0.41%)